nach oben

Erschienen in:

21.11.2019 | Original Article

Unaffected bone mineral density in Danish children and adolescents with type 1 diabetes

verfasst von: Jens Otto Broby Madsen, Camilla Winther Herskin, Bo Zerahn, Andreas Kryger Jensen, Niklas Rye Jørgensen, Birthe Susanne Olsen, Flemming Pociot, Jesper Johannesen

Erschienen in: Journal of Bone and Mineral Metabolism | Ausgabe 3/2020

Einloggen, um Zugang zu erhalten

Abstract

Aims

Adults with type 1 diabetes mellitus (T1D) have decreased bone mineral density (BMD). Our study aimed at determining BMD and the association to metabolic control in children and adolescents with T1D.

Methods

244 patients (113 girls) with a median age of 14.3 years and T1D duration of 1–16 years were included. A dual-energy X-ray absorptiometry scan assessed BMD Z-scores excluding the head (total body less head, TBLH). TBLH-BMD were then investigated for associations to diabetes relevant variables such as HbA1c, insulin treatment, anthropometry and physical activity.

Results

In all participants the TBLH-BMD Z-score (0.22 ± 0.96) was significantly higher than the references. Separated by sex, TBLH-BMD Z-score in boys (0.11 ± 0.84) was no different from healthy peers whereas TBLH-BMD Z-score was significantly higher in girls (0.36 ± 1.09). The higher TBLH-BMD Z-score in girls were explained by higher BMI Z-scores. Participants with assumed final height (based on age) had an average TBLH-BMD Z-score of 0.78 ± 1.06, significantly higher than references independent of gender, HbA1c, height- and weight Z-scores. Multiple regression analyses showed that TBLH BMD Z-score associated negatively to HbA1c (P = 0.003), pump treatment (P = 0.019) and screen-time (P = 0.005) and positively to weight Z-score (P < 0.001). Physical activity, sex and puberty did not significantly associate to TBLH-BMD Z-score.

Conclusion

Unlike adults with T1D, BMD is not decreased in children and adolescents with T1D and even elevated after attained final height. As HbA1c negatively associates to BMD, decreased BMD may progress over time. Whether changes in microarchitecture or bone metabolism precede changes in BMD needs further investigation.

Salvatoni A, Mancassola G, Biasoli R, Cardani R, Salvatore S, Broggini M, Nespoli L (2004) Bone mineral density in diabetic children and adolescents: a follow-up study. Bone 34:900–904PubMed

Saki F, Sheikhi A, Omrani GHR, Karimi H, Dabbaghmanesh MH, Mousavinasab SN (2017) Evaluation of bone mineral density in children with type I diabetes mellitus and relationship to serum levels of osteopontin. Drug Res 67:527–533

Léger J, Marinovic D, Alberti C, Dorgeret S, Chevenne D, Marchal CL, Tubiana-Rufi N, Sebag G, Czernichow P (2006) Lower bone mineral content in children with type 1 diabetes mellitus is linked to female sex, low insulin-like growth factor type I levels, and high insulin requirement. J Clin Endocrinol Metab 91:3947–3953PubMed

Heilman K, Zilmer M, Zilmer K, Tillmann V (2009) Lower bone mineral density in children with type 1 diabetes is associated with poor glycemic control and higher serum ICAM-1 and urinary isoprostane levels. J Bone Miner Metab 27:598–604PubMed

Bechtold S, Putzker S, Bonfig W, Fuchs O, Dirlenbach I, Schwarz HP (2007) Bone size normalizes with age in children and adolescents with type 1 diabetes. Diabetes Care 30:2046–2050PubMed

Camurdan MO, Ciaz P, Bideci A, Demirel F (2007) Role of hemoglobin A(1c), duration and puberty on bone mineral density in diabetic children. Pediatr Int Off J Jpn Pediatr Soc 49:645–651

Brandao FR, Vicente EJ, Daltro CH, Sacramento M, Moreira A, Adan L (2007) Bone metabolism is linked to disease duration and metabolic control in type 1 diabetes mellitus. Diabetes Res Clin Pract 78:334–339PubMed

Khoshhal KI, Sheweita SA, Al-Maghamsi MS, Habeb AM (2015) Does type 1 diabetes mellitus affect bone quality in prepubertal children? J Taibah Univ Med Sci 10:300–305

Saha MT, Sievänen H, Salo MK, Tulokas S, Saha HH (2009) Bone mass and structure in adolescents with type 1 diabetes compared to healthy peers. Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA 20:1401–1406

10.

Liu EY, Wactawski-Wende J, Donahue RP, Dmochowski J, Hovey KM, Quattrin T (2003) Does low bone mineral density start in post-teenage years in women with type 1 diabetes? Diabetes Care 26:2365–2369PubMed

11.

Gunczler P, Lanes R, Paoli M, Martinis R, Villaroel O, Weisinger JR (2001) Decreased bone mineral density and bone formation markers shortly after diagnosis of clinical type 1 diabetes mellitus. J Pediatr Endocrinol Metab JPEM 14:525–528PubMed

12.

Ersoy B, Gökşen D, Darcan S, Mavi E, Oztürk C (1999) Evaluation of bone mineral density in children with diabetes mellitus. Indian J Pediatr 66:375–379PubMed

13.

De Schepper J, Smitz J, Rosseneu S, Bollen P, Louis O (1998) Lumbar spine bone mineral density in diabetic children with recent onset. Horm Res 50:193–196PubMed

14.

Vestergaard P (2007) Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes—a meta-analysis. Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA 18:427–444

15.

Heap J, Murray MA, Miller SC, Jalili T, Moyer-Mileur LJ (2004) Alterations in bone characteristics associated with glycemic control in adolescents with type 1 diabetes mellitus. J Pediatr 144:56–62PubMed

16.

Moyer-Mileur LJ, Dixon SB, Quick JL, Askew EW, Murray MA (2004) Bone mineral acquisition in adolescents with type 1 diabetes. J Pediatr 145:662–669PubMed

17.

Pascual J, Argente J, Lopez MB, Muñoz M, Martinez G, Vazquez MA, Jodar E, Perez-Cano R, Hawkins F (1998) Bone mineral density in children and adolescents with diabetes mellitus type 1 of recent onset. Calcif Tissue Int 62:31–35PubMed

18.

Valerio G, del Puente A, Esposito-del Puente A, Buono P, Mozzillo E, Franzese A (2002) The lumbar bone mineral density is affected by long-term poor metabolic control in adolescents with type 1 diabetes mellitus. Horm Res 58:266–272PubMed

19.

Vargas DM, Rigotti T, Gütz CNRM, Lobe MCS, de Fernades JA (2003) Bone mineralization in children and adolescents with type 1 diabetes. J Pediatr (Rio J) 79:253–258

20.

Viña Simón E, Bueno Lozano G, Armadá Maresca MI, Ruibal Francisco JL, Fernández Pérez C, Lozano Tonkin C, Casasdo de Frías E (2000) Bone mineral density in juvenile-onset diabetes mellitus. An Esp Pediatr 52:507–515PubMed

21.

Pan H, Wu N, Yang T, He W (2014) Association between bone mineral density and type 1 diabetes mellitus: a meta-analysis of cross-sectional studies. Diabetes Metab Res Rev 30:531–542PubMed

22.

Abo-El-Asrar M, Farid S, El Maraghy M, Mohamedeen A (2011) Serum osteocalcin, zinc nutritive status and bone turnover in children and adolescents with type 1 diabetes mellitus. J Diabetes Metab 2:128

23.

Abd El Dayem SM, El-Shehaby AM, Abd El Gafar A, Fawzy A, Salama H (2011) Bone density, body composition, and markers of bone remodeling in type 1 diabetic patients. Scand J Clin Lab Investig 71:387–393

24.

Maggio ABR, Ferrari S, Kraenzlin M, Marchand LM, Schwitzgebel V, Beghetti M, Rizzoli R, Farpour-Lambert NJ (2010) Decreased bone turnover in children and adolescents with well controlled type 1 diabetes. J Pediatr Endocrinol Metab JPEM 23:697–707PubMed

25.

Karagüzel G, Akçurin S, Ozdem S, Boz A, Bircan I (2006) Bone mineral density and alterations of bone metabolism in children and adolescents with type 1 diabetes mellitus. J Pediatr Endocrinol Metab JPEM 19:805–814PubMed

26.

Mastrandrea LD, Wactawski-Wende J, Donahue RP, Hovey KM, Clark A, Quattrin T (2008) Young women with type 1 diabetes have lower bone mineral density that persists over time. Diabetes Care 31:1729–1735PubMedPubMedCentral

27.

Janner M, Ballinari P, Mullis PE, Flück CE (2010) High prevalence of vitamin D deficiency in children and adolescents with type 1 diabetes. Swiss Med Wkly 140:w13091PubMed

28.

Schwarz P, Sørensen HA, Momsen G, Friis T, Transbøl I, McNair P (1992) Hypocalcemia and parathyroid hormone responsiveness in diabetes mellitus: a tri-sodium-citrate clamp study. Acta Endocrinol 126:260–263PubMed

29.

Saggese G, Bertelloni S, Baroncelli GI, Federico G, Calisti L, Fusaro C (1989) Bone demineralization and impaired mineral metabolism in insulin-dependent diabetes mellitus. A possible role of magnesium deficiency. Helv Paediatr Acta 43:405–414PubMed

30.

Lee SY, Gallagher D (2008) Assessment methods in human body composition. Curr Opin Clin Nutr Metab Care 11:566–572PubMedPubMedCentral

31.

Bogunovic L, Doyle SM, Vogiatzi MG (2009) Measurement of bone density in the pediatric population. Curr Opin Pediatr 21:77–82PubMed

32.

Crabtree NJ, Arabi A, Bachrach LK, Fewtrell M, El-Hajj Fuleihan G, Kecskemethy HH, Jaworski M, Gordon CM (2014) Dual-energy X-ray absorptiometry interpretation and reporting in children and adolescents: the revised 2013 ISCD Pediatric Official Positions. J Clin Densitom Off J Int Soc Clin Densitom 17:225–242

33.

Taylor A, Konrad PT, Norman ME, Harcke HT (1997) Total body bone mineral density in young children: influence of head bone mineral density. J Bone Miner Res Off J Am Soc Bone Miner Res 12:652–655

34.

Xu H, Chen J-X, Gong J, Zhang T-M, Wu Q-L, Yuan Z-M, Wang J-P (2007) Normal reference for bone density in healthy Chinese children. J Clin Densitom Off J Int Soc Clin Densitom 10:266–275

35.

Marshall WA, Tanner JM (1969) Variations in pattern of pubertal changes in girls. Arch Dis Child 44:291–303PubMedPubMedCentral

36.

Marshall WA, Tanner JM (1970) Variations in the pattern of pubertal changes in boys. Arch Dis Child 45:13–23PubMedPubMedCentral

37.

Tinggaard J, Aksglaede L, Sørensen K, Mouritsen A, Wohlfahrt-Veje C, Hagen CP, Mieritz MG, Jørgensen N, Wolthers OD, Heuck C, Pedersen JH, Main KM, Juul A (2014) The 2014 Danish references from birth to 20 years for height, weight and body mass index. Acta Paediatr 103:214–224PubMed

38.

Svensson J, Schwandt A, Pacaud D, Beltrand J, Birkebaek NH, Cardona-Hernandez R, Casteels K, Castro S, Cherubini V, Cody D, Fisch N, Hasnani D, Kordonouri O, Kosteria I, Luczay A, Pundziute-Lyckå A, Maffeis C, Piccini B, Luxmi P, Sumnik Z, de Beaufort C (2018) The influence of treatment, age at onset, and metabolic control on height in children and adolescents with type 1 diabetes—a SWEET collaborative study. Pediatr Diabetes 19:1441–1450PubMed

39.

Roggen I, Gies I, Vanbesien J, Louis O, De Schepper J (2013) Trabecular bone mineral density and bone geometry of the distal radius at completion of pubertal growth in childhood type 1 diabetes. Horm Res Paediatr 79:68–74PubMed

40.

Bechtold S, Dirlenbach I, Raile K, Noelle V, Bonfig W, Schwarz HP (2006) Early manifestation of type 1 diabetes in children is a risk factor for changed bone geometry: data using peripheral quantitative computed tomography. Pediatrics 118:e627–e634PubMed

41.

Shanbhogue VV, Hansen S, Frost M, Jørgensen NR, Hermann AP, Henriksen JE, Brixen K (2015) Bone geometry, volumetric density, microarchitecture, and estimated bone strength assessed by HR-pQCT in adult patients with type 1 diabetes mellitus. J Bone Miner Res Off J Am Soc Bone Miner Res 30:2188–2199

42.

Horlick M, Wang J, Pierson RN, Thornton JC (2004) Prediction models for evaluation of total-body bone mass with dual-energy X-ray absorptiometry among children and adolescents. Pediatrics 114:e337–e345PubMed

43.

del Rio L, Carrascosa A, Pons F, Gusinyé M, Yeste D, Domenech FM (1994) Bone mineral density of the lumbar spine in white Mediterranean Spanish children and adolescents: changes related to age, sex, and puberty. Pediatr Res 35:362–366PubMed

44.

Gutefeldt K, Hedman CA, Thyberg ISM, Bachrach-Lindström M, Spångeus A, Arnqvist HJ (2018) Dysregulated growth hormone-insulin-like growth factor-1 axis in adult type 1 diabetes with long duration. Clin Endocrinol (Oxf) 89:424–430

Titel: Unaffected bone mineral density in Danish children and adolescents with type 1 diabetes
verfasst von: Jens Otto Broby Madsen
Camilla Winther Herskin
Bo Zerahn
Andreas Kryger Jensen
Niklas Rye Jørgensen
Birthe Susanne Olsen
Flemming Pociot
Jesper Johannesen
Publikationsdatum: 21.11.2019
Verlag: Springer Singapore
Erschienen in: Journal of Bone and Mineral Metabolism / Ausgabe 3/2020
Print ISSN: 0914-8779
Elektronische ISSN: 1435-5604
DOI: https://doi.org/10.1007/s00774-019-01058-0

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

25.04.2024 | Hypotonie | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Unaffected bone mineral density in Danish children and adolescents with type 1 diabetes

Abstract

Aims

Methods

Results

Conclusion

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin

Springer Medizin

Abstract

Aims

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2020

Mineralization of cortical bone during maturation and growth in rabbits

Coding and prescription rates of osteoporosis are low among distal radius fracture patients in Japan

MiR-203 regulates estrogen receptor α and cartilage degradation in IL-1β-stimulated chondrocytes

18F-NaF-PET/CT in patients with primary hyperparathyroidism and brown tumors

Influence of sarcopenia on bone health parameters in a group of eumenorrheic obese premenopausal women

Correction to: Warfarin calcifies human aortic valve interstitial cells at high-phosphate conditions via pregnane X receptor

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin